Dentium Co Ltd
KRX:145720
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Teladoc Health Inc
NYSE:TDOC
|
Health Care
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
Health Care
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
Lockheed Martin Corp
NYSE:LMT
|
Aerospace & Defense
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
Pharmaceuticals
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Micron Technology Inc
NASDAQ:MU
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
55 700
146 800
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Teladoc Health Inc
NYSE:TDOC
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Hims & Hers Health Inc
NYSE:HIMS
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
Lockheed Martin Corp
NYSE:LMT
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Eli Lilly and Co
NYSE:LLY
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Micron Technology Inc
NASDAQ:MU
|
US |
This alert will be permanently deleted.
Dentium Co Ltd
Dentium Co Ltd
Cash & Cash Equivalents
Dentium Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dentium Co Ltd
KRX:145720
|
Cash & Cash Equivalents
₩86.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biodyne Co Ltd
KOSDAQ:314930
|
Cash & Cash Equivalents
₩9.7B
|
CAGR 3-Years
48%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Cash & Cash Equivalents
₩45.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Cash & Cash Equivalents
₩52.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
115%
|
CAGR 10-Years
N/A
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Cash & Cash Equivalents
₩24.3B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lutronic Corp
KOSDAQ:085370
|
Cash & Cash Equivalents
₩50B
|
CAGR 3-Years
64%
|
CAGR 5-Years
69%
|
CAGR 10-Years
33%
|
|
Dentium Co Ltd
Glance View
Dentium Co., Ltd. engages in the manufacturing of dental supplies and equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2017-03-15. The Company’s products include artificial dental implants, dental Equipment, synthetic bone for dentistry and other dental medical devices.
See Also
What is Dentium Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
86.6B
KRW
Based on the financial report for Jun 30, 2024, Dentium Co Ltd's Cash & Cash Equivalents amounts to 86.6B KRW.
What is Dentium Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
17%
Over the last year, the Cash & Cash Equivalents growth was 27%. The average annual Cash & Cash Equivalents growth rates for Dentium Co Ltd have been 13% over the past three years , 17% over the past five years .
You don't have any saved screeners yet
